Signaling Pathway
Verzistobart is a monoclonal antibody of the IgG1?? class, specifically designed to bind to the hepatitis A virus cellular receptor, HAVCR2. This targeted interaction is crucial for research focused on the pathogenesis and therapeutic interventions of hepatitis A, providing a valuable tool for both in vitro and in vivo studies.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Verzistobart is a monoclonal antibody of the IgG1?? class, specifically designed to bind to the hepatitis A virus cellular receptor, HAVCR2. This targeted interaction is crucial for research focused on the pathogenesis and therapeutic interventions of hepatitis A, providing a valuable tool for both in vitro and in vivo studies. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
